Table 1.
Patients’ characteristics in the validation dataset for this study.
| Characteristic | Value |
|---|---|
| Total number of patients | 67 |
| Gender | Male: 45 (67.2%) |
| Female: 22 (32.8%) | |
| Mean age | 55.2 ± 16.2 (range: 11–83) |
| Grade | III: 22 (32.8%) |
| IV: 45 (67.2%) | |
| Histological type | GBM: 45 (67.2%) |
| AA: 8 (11.9%) | |
| AO: 9 (13.4%) | |
| AOA: 5 (7.5%) | |
| IDH mutation status in GBM (n = 45) | Mutated: 2 (4.4%) |
| Wild type: 19 (42.2%) | |
| Unknown: 24 (53.3%) | |
| MGMT methylation status in GBM (n = 45) | Methylated: 7 (15.6%) |
| Unmethylated: 13 (28.9%) | |
| Unknown: 25 (55.6%) |
GBM: glioblastoma, AA: anaplastic astrocytoma, AO: anaplastic oligodendroglioma, AOA: anaplastic oligoastrocytoma, IDH: isocitrate dehydrogenase, MGMT: O6-methylguanine-DNA methyltransferase.